Serdar CEYLANER, Fatma Derya BULUT, Berna ŞEKER YILMAZ, Sebile KILAVUZ, Halise Neslihan ÖNENLİ MUNGAN, Deniz KÖR

Clinical and molecular findings in 37 Turkish patients with isolated methylmalonic acidemia

Background/aim: Isolated methylmalonic acidemia (MMA) is caused by complete or partial deficiency of the enzyme methylmalonylCoA mutase (mut0 or mut– enzymatic subtype), a defect of its cofactor adenosyl-cobalamin (cblA, cblB, or cblD-MMA), or deficiency of the enzyme methylmalonyl-CoA epimerase. While onset of the disease ranges from the neonatal period to adulthood, most cases present with lethargy, vomiting and ketoacidosis in the early infancy. Major secondary complications are; growth failure, developmental delay, interstitial nephritis with progressive renal failure, basal ganglia injury and cardiomyopathy. We aimed to demonstrate clinical and molecular findings based on long-term follow up in our patient cohort. Materials and methods: The study includes 37 Turkish patients with isolated MMA who were followed up for long term complications 1 to 14 years. All patients were followed up regularly with clinical, biochemical and dietary monitoring to determine long term complications. Next Generation Sequencing technique was used for mutation screening in five disease-causing genes including; MUT, MMAA, MMAB, MMADHC, MCEE genes. Mutation screening identified 30 different types of mutations. Results: While 28 of these mutations were previously reported, one novel MMAA mutation p.H382Pfs*24 (c.1145delA) and one novel MUT mutation IVS3+1G>T(c.752+1G>T) has been reported. The most common clinical complications were growth retardation, renal involvement, mental motor retardation and developmental delay. Furthermore, one of our patients developed cardiomyopathy, another one died because of hepatic failure and one presented with lactic acidosis after linezolid exposure. Conclusion: We have detected two novel mutations, including one splice-site mutation in the MUT gene and one frame shift mutation in the MMAA gene in 37 Turkish patients. We confirm the genotype-phenotype correlation in the study population according to the long-term complications.Key words: Methylmalonic acidemia, novel mutations, complications, outcome

PDF

___

1. Vatanavicharn N, Champattanachai V, Liammongkolkul S, Sawangareetrakul P, Keeratichamroen S et al. Clinical and molecular findings in Thai patients with isolated methylmalonic acidemia. Molecular Genetics of Metabolism 2012; 106 (4): 424-429. doi: 10.1016/j.ymgme.2012.05.012
2. Martinez MA, Rincon A, Desviat LR, Merinero B, Ugarte M et al. Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants. Molecular Genetics of Metabolism 2005; 84(4): 317- 325. doi: 10.1016/j.ymgme.2012.05.012
3. Manoli I, Sloan JL, Venditti CP. Isolated methylmalonic acidemia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (editors). SourceGeneReviews® [Internet]. Seattle; 2005.
4. Dobson CM, Wai T, Leclerc D, Kadir H, Narang M et al. Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria. Human Molecular Genetics 2002; 11 (26): 3361-3369. doi: 10.1093/hmg/11.26.3361
5. Dobson CM, Wai T, Leclerc D, Wilson A, Wu X et al. Identification of the gene responsible for the cblA complementation group of vitamin B12 responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. Proceedings of the National Academy of Sciences of the United States of America 2002; 99 (24): 15554-15559. doi: 10.1073/pnas.242614799
6. Coelho D, Suormala T, Stucki M, Lerner-Ellis JP, Rosenblatt DS et al. Gene identification for the cblD defect of vitamin B12 metabolism. The New England Journal of Medicine 2008; 358 (14): 1454-1564. doi: 10.1056/NEJMoa072200
7. Abily-Donval L, Torre S, Samson A, Sudrie-Arnaud B, Acquaviva C et al. Methylmalonyl-CoA epimerase deficiency mimicking propionic aciduria. International Journal of Molecular Sciences 2017; 18 (11): 2294. doi: 10.3390/ ijms18112294
8. Fenton WA, Gravel RA, Rosenblatt. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (editors). The Metabolic and Molecular Bases of Inherited Disease. New York, NY, USA: McGrawHill; 2001. pp 2165-2193.
9. Ciani F, Donati MA, Tulli G, Poggi GM, Pasquini E et al. Lethal late onset cblB methylmalonic aciduria. Critical Care Medicine 2000; 28 (6): 2119-2121. doi: 10.1097/00003246-200006000- 00078
10. Saini N, Malhotra A, Chhabra S, Chhabra S. Methylmalonic acidemia mimicking diabetic ketoacidosis and septic shock in infants. Indian Society of Critical Care Medicine 2015; 19 (3): 183-185. doi: 10.4103/0972-5229.152776
11. Imataka G, Sakamoto O, Yamanouchi H, Yoshihara S, OmuraHasegawa Y et al. Novel c.2216T > C (p.I739T) mutation in exon 13 and c.1481T > A (p.L494X) mutation in exon 8 of MUT gene in a female with methylmalonic acidemia. Cell Biochemistry and Biophysics 2013; 67 (1): 185-187. doi: 10.1007/s12013-013-9532-9
12. Chandler RJ, Venditti CP. Genetic and genomic systems to study methylmalonic acidemia. Molecular Genetics of Metabolism 2005; 86 (1-2): 34-43. doi: 10.1016/j.ymgme.2005.07.020
13. Chandler RJ, Zerfas PM, Shanske S, Sloan J, Hoffmann V et al. Mitochondrial dysfunction in mut methylmalonic acidemia. The Journal of the Federation of American Societies for Experimental Biology 2009; 23 (4): 1252-1261. doi: 10.1096/ fj.08-121848
14. de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F et al. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatric Research 2009; 66 (1): 91-95. doi: 10.1203/PDR.0b013e3181a7c270
15. Dündar H, Özgül RK, Güzel-Ozantürk A, Dursun A, Sivri S et al. Microarray based mutational analysis of patients with methylmalonic acidemia: identification of 10 novel mutations. Molecular Genetics of Metabolism 2012; 106 (4): 419-423. doi: 10.1016/j.ymgme.2012.05.014
16. Dionisi-Vici C, Deodato F, Roschinger W, Rhead W, Wilcken B. ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. Journal of Inherited Metabolic Disease 2006; 29 (2-3): 383-389. doi: 10.1007/s10545-006-0278-z
17. Touati G, Valayannopoulos V, Mention K, de Lonlay P, Jouvet P et al. Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture. Journal of Inherited Metabolic Disease 2006; 29 (2-3): 288-298. doi: 10.1007/s10545-006-0351-7
18. Walter JH, Michalski A, Wilson WM, Leonard JV, Barratt TM et al. Chronic renal failure in methylmalonic acidaemia. European Journal of Pediatrics 1989; 148 (4): 344-348. doi: 10.1007/bf00444131
19. Mardach R, Verity MA, Cederbaum SD. Clinical, pathological, and biochemical studies in a patient with propionic acidemia and fatal cardiomyopathy. Molecular Genetics of Metabolism 2005; 85 (4): 286-290. doi: 10.1016/j.ymgme.2005.04.004
20. Brusque AM, Borba Rosa R, Schuck PF, Dalcin KB, Ribeiro CA et al. Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochemistry International 2002; 40 (7): 593-601. doi: 10.1016/s0197-0186(01)00130-9
21. Burlina AP, Manara R, Calderone M, Catuogno S, Burlina AB. Diffusion weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria. Journal of Inherited Metabolic Disease 2003; 26 (5): 417-422. doi: 10.1023/a:1025106909213
22. Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clinical Journal of American Society of Nephrology 2009; 4 (11): 1832-1843. doi: 10.2215/ CJN.0164030
23. Yiyang M, Danping D, Haiying J, Yangyang W. The risk factors of linezolidinduced lactic acidosis: a case report and review. Medicine (Baltimore) 2018; 97 (36): e12114. doi: 10.1097/ MD.0000000000012114
24. Horster F, Baumgartner MR, Viardot C, Suormala T, Burgard P et al. Longterm outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA,cblB). Pediatric Research 2007; 62 (2): 225-230. doi: 10.1203/ PDR.0b013e3180a0325f
25. Worgan LC, Niles K, Tirone JC, Hofmann A, Verner A et al. Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype. Human Mutation 2006; 27 (1): 31-43. doi: 10.1002/humu.20258
26. Acquaviva C, Benoist JF, Pereira S, Callebaut I, Koskas T et al. Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut(0) and mutforms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene. Human Mutation 2005; 25 (2): 167-176. doi: 10.1002/humu.20128
27. Lempp TJ, Suormala T, Siegenthaler R, Baumgartner ER, Fowler B et al. Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut- methylmalonic aciduria: identification of seven novel mutations. Molecular Genetics of Metabolism 2007; 90 (3): 284-290. doi: 10.1016/j.ymgme.2006.10.002
28. Acquaviva C, Benoist JF, Callebaut I, Guffon N, Ogier de Baulny H et al. N219Y, a new frequent mutation among mut (degree) forms of methylmalonic acidemia in Caucasian patients. European Journal of Human Genetics 2001; 9 (8): 577-582. doi: 10.1038/sj.ejhg.5200675
29. Forny P, SchnellmannAS, Buerer C, Lutz S, Fowler B et al. Molecular genetic characterization of 151 mut‐ type methylmalonic aciduria patients and identification of 41 novel mutations in MUT. Human Mutation 2016; 37 (8): 745-754. doi: 10.1002/humu.23013
30. Shafaat M, Alaee MR, Rahmanifar A, Setoodeh A, RazzaghyAzar M et al. Autozygosity mapping of methylmalonic acidemia associated genes by short tandem repeat markers facilitates the identification of five novel mutations in an Iranian patient cohort. Metabolic Brain Disease 2018; 33 (5): 1689-1697. doi: 10.1007/s11011-018-0277-4
31. Girisha KM, Shrikiran A, Bidchol AM, Sakamoto O, Gopinath M et al. Novel mutation in an Indian patient with methylmalonic acidemia, cblA type. Indian Journal of Human Genetics 2012; 18 (3): 346-348. doi: 10.4103/0971-6866.108025
32. Coman D, Huang J, McTaggart S, Sakamoto O, Ohura T et al. Renal transplantation in a 14-year-old girl with vitamin B12- responsive cblA-type methylmalonic acidaemia. Pediatric Nephrology 2006; 21 (2): 270-273. doi: 10.1007/s00467-005- 2071-x
33. Guven A, Cebeci N, Dursun A, Aktekin E, Baumgartner M et al. Methylmalonic acidemia mimicking diabetic ketoacidosis in an infant. Pediatric Diabetes 2012; 13 (6): 22-25. doi: 10.1111/j.1399-5448.2011.00784.x
34. Dempsey-Nunez L, Illson ML, Kent J, Huang Q, Brebner A et al. High resolution melting analysis of the MMAA gene in patients with cblA and in those with undiagnosed methylmalonic aciduria. Molecular Genetics of Metabolism 2012; 107 (3): 363-367. doi: 10.1016/j.ymgme.2012.09.012
35. Lerner-Ellis JP, Dobson CM, Wai T, Watkins D, Tirone JC et al. Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism. Human Mutation 2004; 24 (6): 509-516. doi: 10.1002/humu.20104
36. A l k h u n a i z i AM, Al-Sannaa N. Renal involvement in methylmalonic aciduria. Kidney International Reports 2017; 2 (5): 956-960. doi: 10.1016/j.ekir.2017.04.007
37. Jorge-Finnigan A, Aguado C, Sanchez-Alcudia R, Abia D, Richard E et al. Functional and structural analysis of five mutations identified in methylmalonic aciduria cblB type. Human Mutation 2010; 31 (9): 1033-1042. doi: 10.1002/ humu.21307